A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab

@article{Paa2008ACO,
  title={A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab},
  author={Semir Paşa and Abdullah Altintaş and Timuçin Çil and Ramazan Danis and Orhan Ayyildiz and Ekrem Muftuoglu},
  journal={Journal of Thrombosis and Thrombolysis},
  year={2008},
  volume={27},
  pages={220-222}
}
Current treatment options of essential mixed cryoglobulinemia (EMC); include immunosuppressive approaches, such as corticosteroids, cyclophosphamide, plasma exchange, other cytotoxic drugs in moderate to severe manifestations. Some controlled studies have been carried out to assess the efficacy of anti-CD20 monoclonal antibody, rituximab in patients with hepatitis C (HCV) related cryoglobulinemia (CG) and in patients with autoimmune disorders. Recent trials and some case reports demonstrate a… CONTINUE READING

References

Publications referenced by this paper.

Similar Papers

Loading similar papers…